Disruptions in the gut microbiome have been implicated in the pathophysiology of num erous illnesses including diabetes, chronic kidney disease (CKD), obesity, inflammatory bowel disease, dyslipidaemia, cardiovascular disease, cancer and allergic disorders 1 . The metabolites produced by the gut micro biota include shortchain fatty acids (SCFAs), which are generated by the fermentation of indigestible carbohydrates (that is, saccharo lytic fermentation) and have an important role in host metabolism (Fig. 1a) . The main SCFAs produced by the gut microbiota include butyrate, acetate and propionate 1 . In addi tion to being an essential nutrient for host enterocytes, SCFAs modulate insulin sensiti vity, systemic inflammation, and glucose and lipid homeostasis. With respect to energy and glucose metabolism, SCFAs suppress appetite by increasing the release of satiety hormones and stimulating vagal afferent chemorecep tors, increase energy expendi ture by upregulating thermogenesisrelated proteins in the liver and adipose tissue, and increase glucosestimulated insulin secre tion from pancreatic βcells 2 (Fig. 1a) . Mendelian randomization is based on the concept that inheritance of genetic variants at conception is analogous to the randomization process used in clinical tri als. An inherent limitation of this type of analy sis is that it may be difficult to ascertain the direction of causation -in this case, whether host genetic factors induce changes in the gut microbiome or vice versa. Bidirectional Mendelian randomization (also known as reciprocal Mendelian randomization) strives to overcome this uncertainty by performing separate analyses in both directions 7 .
T2DM. In The Environmental Determinants of Diabetes in the Young (TEDDY) study, in which stool microbiomes were analysed monthly from 3 months to up to 5 years of age, the expression of microbial genes involved in the biosynthesis of SCFAs was
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Nature reviews | NepHrology Fig. 1 | Host genetics, gut microbiota SCFAs and risk of diabetes. a | Short-chain fatty acids (SCFAs) generated by the gut microbiota include propionate, acetate and butyrate, which are essential nutrients for colonic cells. SCFAs also modulate host energy and glucose metabolism through effects on appetite, energy expenditure and insulin secretion. b | Human genetic variants can predict opposing pathways involved in the metabolism of SCFAs by gut microbiota. Increased faecal propionate is associated with an increased risk of type 2 diabetes mellitus (detrimental to the host), whereas increased butyrate production is associated with an improved response of pancreatic β-cells to insulin (beneficial to the host).
The first step of the analysis reported by Sanna and colleagues focused on genome wide association study (GWAS) data from the Dutch LifeLinesDEEP (LLDEEP) cohort of normoglycaemic individuals, to identify host genetic predictors of gut microbiome features that correlated with 17 predefined anthropo metric and glycaemic traits. The analysed traits included body mass index, waisttohip ratio, fasting glucose, insulin and proinsulin, 2hour glucose, homeostasis model assess ment of insulin resistance (HOMAIR) and βcell function (HOMAB), glycated haemo globin A 1c , T2DM and seven insulinresponse parameters measured during an oral glucose tolerance test. Subsequently, GWAS data from publicly available databases (MAGIC, GIANT and DIAGRAM) were also included in the bidirectional Mendelian randomization analyses that tested the causal relationship between 245 microbiome features of interest identified in the Dutch cohort, and the afore mentioned 17 anthropometric and glycaemic traits. Finally, the researchers validated their findings using 500,000 samples from the UK Biobank consortium.
The study identified host genetic predictors in two major areas of microbial metabolism, both of which pertained to SCFAs (Fig. 1b) . First, host genetic variants predicted increased activity of the butyrateproducing microbi ome pathway PWY5022, which is linked to 4aminobutanoate degradation and was asso ciated with improved insulin secretion during an oral glucose tolerance test (but not with the prevalence of T2DM). The presence of butyrateproducing bacteria Eubacterium rectale and Roseburia intestinalis correlated with the abundance of PWY5022 activity. Second, host genetic variants predicted higher faecal propionate levels, which were associated with an increased risk of T2DM. The researchers hypothesized that a combination of increased microbial propionate production and impaired host absorption of propionate might lead to increased faecal propionate levels.
A host-microbiome bidirectional rela tionship has also been described for CKD. Influx of retained waste products, includ ing urea, into the intestinal lumen alters the microbiota composition, resulting in the gen eration of uraemic toxins such as indole and pcresyl compounds. These toxins enter the bloodstream, induce chronic inflammation and contribute to the progression of kidney function and minimize the risk of developing diabetes mellitus. 
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In 1998, the National Kidney Foundation (NKF) Task Force issued a report on the epidemic of cardiovascular disease (CVD) in patients with end stage renal disease (ESRD). This report stated that adults aged 25-34 years were >100 times more likely to die of cardio vascular causes than their age matched healthy counterparts in the general population 1 . Recognizing a lack of data on CVD, Parekh et al. 2 subsequently conducted an observational cohort study of children and young adults (aged 0-30 years) who were registered in the United States Renal Cardiovascular disease (CVD) is a leading cause of death in young adults with incident end-stage renal disease (ESRD). Unlike children with ESRD, young adults with incident ESRD have high prevalence of diabetes, coronary artery disease and heart failure. These cardiovascular risk factors are associated with increased CVD-related hospitalizations and mortality in young adults.
